Megan Odio's Colleagues at Deciphera Pharmaceuticals
Jessica Desfosses
Associate Director, Clinical Business Operations, Site Payments
Megan Odio's Contact Details
781-209-6400
Boston, Massachusetts, United States
Deciphera Pharmaceuticals
Megan Odio's Company Details
Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera's FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Australia, Canada, Hong Kong, and China. For more information, visit www.deciphera.com.